Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01888185 · ClinicalTrials.gov registry record
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 290
- Enrollment target
NCT01888185: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT01888185 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01888185 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
This study is designed to determine if magnetic resonance imaging (MRI) measures can be used to diagnose and monitor the progression of Parkinson's disease (PD) while distinguishing between PD and parkinsonisms \[conditions that are PD look-a-like diseases such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA)\] when combined with changes in certain proteins in body fluids that are related to iron (Fe).
Primary Outcome
Substantia Nigra (SN) FA and R2\* values in PD subjects will be compared with control subjects and correlated with clinical and behavioral measures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2012-12 |
| Est. Completion | 2019-12-31 |
What the finished NCT01888185 record still lists
NCT01888185 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01888185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01888185 about?
NCT01888185 is a clinical study titled "Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)". This study is designed to determine if magnetic resonance imaging (MRI) measures can be used to diagnose and monitor the progression of Parkinson's disease (PD) while distinguishing between PD and parkinsonisms \[conditions that are PD look-a-like diseases such as progressive supranuclear palsy (PSP...
What is the current status of trial NCT01888185?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2012-12. Estimated completion is 2019-12-31.
Who is sponsoring clinical trial NCT01888185?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia